Publications and communications of Nadia WITHOFS

Steenhout, C., Deprez, L., Hustinx, R., & Withofs, N. (January 2025). Brain Tumor Assessment: Integrating PET/Computed Tomography and MR Imaging Modalities. PET Clinics, 20 (1), 165 - 174. doi:10.1016/j.cpet.2024.09.003

Bocuzzi, V., Bridoux, J., PIROTTE, M., Withofs, N., Hustinx, R., D'Huyvetter, M., Caers, J., & Marcion, G. (05 November 2024). CD38 as theranostic target in oncology. Journal of Translational Medicine, 22 (1), 998. doi:10.1186/s12967-024-05768-6

Stoffels, M., Cousin, F., Lamande, M., Denis, C., Waltregny, D., Hustinx, R., Sautois, B., & Withofs, N. (2024). Characterization of exclusive rib lesions detected by [68Ga]Ga-PSMA-11 PET/CT. Nuclear Medicine Communications. doi:10.1097/MNM.0000000000001919

Withofs, N., Bonnet, C., & Hustinx, R. (October 2024). 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin's and Non-Hodgkin Lymphomas. PET Clinics, 19 (4), 447 - 462. doi:10.1016/j.cpet.2024.05.001

Nanni, C., Deroose, C. M., Balogova, S., Lapa, C., Withofs, N., Subesinghe, M., Jamet, B., Zamagni, E., Ippolito, D., Delforge, M., & Kraeber-Bodéré, F. (2024). EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-024-06858-9

Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Caers, J., & Bridoux, J. (30 May 2024). Targeted Alpha Therapy for the treatment of multiple myeloma using CD38-targeting sdAb 2F8 [Poster presentation]. Interuniversity PhD student day, Louvain-La-Neuve, Belgium.

MARCHIORI, S., Cousin, F., Papadopoulos, I., Bernard, C., THYS, M., DE PRIJCK, B., Pirotte, M., Donneau, A.-F., Hustinx, R., Caers, J., & Withofs, N. (28 May 2024). Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma. EJNMMI Research, 14 (1), 51. doi:10.1186/s13550-024-01113-6

Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Brans, A., Dumoulin, M., Caers, J., & Bridoux, J. (06 February 2024). CD38-based Targeted Alpha Therapy for the treatment of multiple myeloma [Poster presentation]. Congrès Télévie 2024, Bruxelles, Belgium.

LUCIA, F., Withofs, N., Lovinfosse, P., & Hustinx, R. (2024). TEP/TDM en radiothérapie : indications et perspectives. Revue Médicale de Liège.

Withofs, N. (21 September 2023). LES RADIOTRACEURS AUTRES QUE LE PSMA-LIGAND POUR L’IMAGERIE TEP DU CANCER DE PROSTATE. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 47 (5), 281-290. doi:10.1016/j.mednuc.2023.07.008

Vandenberghe, S., Muller, F. M., Withofs, N., Dadgar, M., Maebe, J., Vervenne, B., Akl, M. A., Xue, S., Shi, K., Sportelli, G., Belcari, N., Hustinx, R., Vanhove, C., & Karp, J. S. (2023). Walk-through flat panel total-body PET: a patient-centered design for high throughput imaging at lower cost using DOI-capable high-resolution monolithic detectors. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06341-x

Nanni, C., Kobe, C., Baeßler, B., Baues, C., Boellaard, R., Borchmann, P., Buck, A., Buvat, I., Chapuy, B., Cheson, B. D., Chrzan, R., Cottereau, A.-S., Dührsen, U., Eikenes, L., Hutchings, M., Jurczak, W., Kraeber-Bodéré, F., Lopci, E., Luminari, S., ... Kunikowska, J. (May 2023). European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. The Lancet Haematology, 10 (5), 367 - e381. doi:10.1016/S2352-3026(23)00030-3

WITHOFS, N., Kumar, R., Alavi, A., & HUSTINX, R. (July 2022). Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions. PET Clinics, 17 (3), 327-342. doi:10.1016/j.cpet.2022.03.004

Denis, C., COUSIN, F., De Laere, B., HUSTINX, R., SAUTOIS, B.* , & WITHOFS, N.*. (21 April 2022). Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice. Journal of Nuclear Medicine, 63 (12), 1815-1821. doi:10.2967/jnumed.121.263611
* These authors have contributed equally to this work.

Lamaye, C., Bastin, C., BERNARD, C., WITHOFS, N., HUSTINX, R., & SALMON, E. (April 2022). Analyse comparative de la distribution cérébrale du [18F]FDG dans une population de patients souffrant de maladie d’Alzheimer présentant ou non des antécédents familiaux de démence. Revue Médicale de Liège, 77 (4), 224-230.

Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E., & D'Huyvetter, M. (2022). Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology, 13, 911080. doi:10.3389/fimmu.2022.911080

Mina, M., JACQUERIE, P., DUQUENNE, J. B., LAVIGNE, J.-P., BOULANGER, Y.-G., BISOGNI, C., Derwael, C., WITHOFS, N., MALAISE, M., & MALAISE, O. (2022). Périostite bilatérale et polyarthrite : à propos d'un cas d'ostéoarthropathie hypertrophique pneumique. Revue Médicale de Liège.

Denis, C., Sakalihasan, S., FRERES, P., WITHOFS, N., & SAUTOIS, B. (2021). Cemiplimab for cisplatin resistant metastatic penile cancer. Case Reports in Oncology, 14, 972-976. doi:10.1159/000517008

WITHOFS, N. (23 October 2020). Use of PET in Multiple Myeloma: Where are we now with Non-FDG [Paper presentation]. 33rd Annual Congress of the European Association of Nuclear Medicine.

CHARLIER, E.* , DEROYER, C.* , NEUVILLE, S., Plener, Z., MALAISE, O., Ciregia, F., Gillet, P., Reuter, G., Salvé, M., Withofs, N., Hustinx, R., de Seny, D., & Malaise, M. (2020). Toward diagnostic relevance of the α(V)β(5), α(V)β(3), and α(V)β(6) integrins in OA: expression within human cartilage and spinal osteophytes. Bone Research, 8, 35. doi:10.1038/s41413-020-00110-4
* These authors have contributed equally to this work.

Derwael, C., Lavergne, O., LOVINFOSSE, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & WITHOFS, N. (2020). Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer. EJNMMI Research, 10 (1), 15. doi:10.1186/s13550-020-0596-4

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600

MARCHETTA, S., WITHOFS, N., ERBA, P. A., HABIB, G., HUSTINX, R., & LANCELLOTTI, P. (August 2017). RADIONUCLIDE IMAGING OF INFECTIVE ENDOCARDITIS: state of art and future perspective. Current Cardiovascular Imaging Reports, 10 (27). doi:10.1007/s12410-017-9425-1

Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528.

Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74.

Hillengass, J., Moulopoulos, L. A., Delorme, S., Koutoulidis, V., Mosebach, J., Hielscher, T., Drake, M., Rajkumar, S. V., Oestergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Waage, A., Goldschmidt, H., Dimopoulos, M. A., Lentzsch, S., Durie, B., ... CAERS, J. (2017). Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood Cancer Journal, 7 (8), 599. doi:10.1038/bcj.2017.78

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845

LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28.

SCHENA, A., Ansseau, M., TRIFFAUX, J.-M., Salmon, E., WITHOFS, N., & Scantamburlo, G. (2014). Le cas clinique du mois : Pseudo-démence dépressive. Revue Médicale de Liège, 69 (2), 64-67.

WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696

WITHOFS, N., & HUSTINX, R. (2014). Imagerie de l'intégrine αvβ3 par PET/CT au 18F-FPRGD2. Revue Médicale de Liège, 69 (Synthèse 2014), 36-40.

SIMONI, P., STULKO, J., BEN MUSTAPHA, S., SCHOYSMAN, L., BIANCHI, E., WITHOFS, N., RACARU, T., CAERS, J., & ALVAREZ MIEZENTSEVA, V. (2013). Bone mass of the calvarium. Skeletal Radiology, 42, 1185-1187. doi:10.1007/s00256-012-1547-6

Govaerts, L., WITHOFS, N., DURIEUX, R., Spote, V., & Hustinx, R. (2012). Acute intramural haematoma of the ascending aorta. European Journal of Nuclear Medicine and Molecular Imaging, 39 (8), 1368-9. doi:10.1007/s00259-012-2130-z

Tran, P. T., Shroff, E. H., Burns, T. F., Thiyagarajan, S., Das, S. T., Zabuawala, T., Chen, J., Cho, Y.-J., Luong, R., Tamayo, P., Salih, T., Aziz, K., Adam, S. J., Vicent, S., Nielsen, C. H., WITHOFS, N., Sweet-Cordero, A., Gambhir, S. S., Rudin, C. M., & Felsher, D. W. (2012). Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS Genetics, 8 (5), 1002650. doi:10.1371/journal.pgen.1002650

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.

WITHOFS, N., COLLIGNON, J., & HUSTINX, R. (2011). Imagerie des métastases osseuses du cancer du sein. Revue Médicale de Liège, 66 (5-6), 291-298.

WITHOFS, N., COLLIGNON, J., RORIVE, A., JERUSALEM, G., & HUSTINX, R. (2011). Hétérogénéité des métastases osseuses du cancer du sein : cas clinique illustrant l'intérêt de combiner différentes techniques d'imagerie. Revue Médicale de Liège, 66 (5-6), 288-290.

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5

COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22.

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2010). Contribution of positron emission tomography in pleural disease. Revue des Maladies Respiratoires, 27 (8), 47-53. doi:10.1016/j.rmr.2009.12.003

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2008). Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale. Revue des Maladies Respiratoires, 25 (2), 129-38. doi:10.1016/S0761-8425(08)71511-0